World's Best Scientists 2026 revealed!
Karin Haustermans

Karin Haustermans

D-Index & Metrics

Medicine

D-Index
89
Citations
36474
World Ranking
12512
National Ranking
146

Karin Haustermans publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Karin Haustermans sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 715 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Karin Haustermans D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Karin Haustermans sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Karin Haustermans is affiliated with KU Leuven in Belgium and has a research focus primarily in the field of medicine, with significant contributions to pulmonary and respiratory medicine, surgery, radiation, radiology, nuclear medicine and imaging, and oncology. Their work covers a range of topics related to cancer management, especially in advanced radiotherapy techniques and cancer diagnosis and treatment.

The main topics of their research include:

  • Advanced Radiotherapy Techniques
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Radiation Therapy and Dosimetry
  • Lung Cancer Diagnosis and Treatment
  • Esophageal Cancer Research and Treatment
  • Gastric Cancer Management and Outcomes

Haustermans has authored numerous papers, some of the recent notable publications are:

  • "Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up", 2022, Annals of Oncology
  • "Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial", 2021, Journal of Clinical Oncology
  • "Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up", 2023, Annals of Oncology
  • "International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer", 2021, Nature Reviews Clinical Oncology
  • "Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer", 2020, Radiotherapy and Oncology

Frequent co-authors that have collaborated extensively with Haustermans include:

  • Sofie Isebaert
  • Uulke A. van der Heide
  • Cédric Draulans
  • Gilles Defraene
  • Floris J. Pos

The majority of their publications appear in the following venues, indicating an emphasis on oncology and radiotherapy research:

  • Radiotherapy and Oncology (71 publications)
  • Annals of Oncology (10 publications)
  • International Journal of Radiation Oncology*Biology*Physics (7 publications)
  • Journal of Clinical Oncology (5 publications)
  • Physics and Imaging in Radiation Oncology (5 publications)

Haustermans' research encompasses multidisciplinary approaches within cancer treatment, particularly focusing on radiation therapy applications and outcomes, with a strong clinical orientation towards improving diagnosis, treatment guidelines, and therapeutic strategies.

Best Publications

  • ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    E. Van Cutsem;A. Cervantes;R. Adam;A. Sobrero

  • Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

    Monique Maas;Patty J. Nelemans;Vincenzo Valentini;Prajnan Das

  • ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    H J Schmoll;E Van Cutsem;A Stein;V Valentini

  • Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

    Michel Bolla;Hendrik Van Poppel;Laurence Collette;Paul van Cangh

  • Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    M. Ducreux;M. Ducreux;A. Sa. Cuhna;C. Caramella;A. Hollebecque

  • Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    F. Lordick;C. Mariette;K. Haustermans;Radka Obermannová

  • Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

    Michel Bolla;Hein van Poppel;Bertrand Tombal;Kris Vekemans

  • Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma

    P Flamen;A Lerut;E Van Cutsem;W De Wever

  • EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

    Cornelis J.H. Van De Velde;Petra G. Boelens;Josep M. Borras;Jan Willem Coebergh

  • Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study

    Doenja M. J. Lambregts;Vincent Vandecaveye;Brunella Barbaro;Frans C. H. Bakers

  • Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer

    P. Flamen;E. Van Cutsem;A. Lerut;J.-P. Cambier

  • Multidisciplinary Rectal Cancer Management : 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)

    Vincenzo Valentini;Cynthia Aristei;Bengt Glimelius;Bruce D. Minsky

  • Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial

    Linda G W Kerkmeijer;Linda G W Kerkmeijer;Veerle H Groen;Floris J Pos;Karin Haustermans

  • Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.

    Jean-Luc Van Laethem;Pascal Hammel;Françoise Mornex;David Azria

  • Definition and delineation of the clinical target volume for rectal cancer

    Sarah Roels;Wim Duthoy;Karin Haustermans;Freddy Penninckx

  • PET-based treatment planning in radiotherapy: a new standard?

    Vincent Grégoire;Karin Haustermans;Xavier Geets;Sarah Roels

  • Mapping of Pelvic Lymph Node Metastases in Prostate Cancer

    Steven Joniau;Laura Van den Bergh;Evelyne Lerut;Christophe M. Deroose

  • Respiration-induced movement of the upper abdominal organs: a pitfall for the three-dimensional conformal radiation treatment of pancreatic cancer

    Barbara Bussels;Laurence Goethals;Michel Feron;Didier Bielen

  • TOPGEAR: A Randomized, Phase III Trial of Perioperative ECF Chemotherapy with or Without Preoperative Chemoradiation for Resectable Gastric Cancer: Interim Results from an International, Intergroup Trial of the AGITG, TROG, EORTC and CCTG

    Trevor Leong;B. Mark Smithers;Karin M G Haustermans;Michael Michael

  • HYPOXIA IN HEAD AND NECK CANCER: HOW MUCH, HOW IMPORTANT?

    Hilde Janssen;Karin Haustermans;A J Balm;A C Begg

Frequent Co-Authors

Steven Joniau
Steven Joniau KU Leuven
Frederik Maes
Frederik Maes KU Leuven
Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Felix M. Mottaghy
Felix M. Mottaghy RWTH Aachen University
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Giorgio Gandaglia
Giorgio Gandaglia Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The field of Medicine in the USA offers a diverse range of online degree options and alternative career pathways. Many healthcare professionals begin or advance their careers by pursuing a healthcare administration degree online, which provides foundational skills for leadership roles in hospitals, clinics, and health systems.

For those seeking advanced management positions, pursuing the cheapest online master degree in healthcare administration can be a strategic and cost-effective choice. These master’s programs often emphasize leadership, policy, and healthcare finance.

Nursing professionals interested in doctoral-level study might explore dnp online programs cheap, which prepare graduates for higher clinical and executive roles. Additionally, aspiring pharmacists can consider fully online study options through online pharmacy schools, which offer the flexibility to balance education with work commitments.

These alternative online pathways often provide more affordable and accessible routes to rewarding positions within the healthcare sector, making them an excellent choice for those looking to enter or advance in healthcare professions.

Best Scientists Citing Karin Haustermans

Trending Scientists

Recently Published Articles